N-hydroxy-4-{5-[4-(5-isopropyl-2-methyl-1,3-thiazol-4-yl)phenoxy]pentoxy}benzamidine 2 ethansulfonic acid salt, process for the preparation thereof and pharmaceutical composition comprising the same
CN101679416A
Aspartate of 1-cyclopropyl-6-fluoro-7-(8-methoxyimino-2,6-diaza- spiro[3, 4]oct-6-yl)-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid, method for preparing the same, and antimicrobial pharmaceu
KR20080092515A
A process for preparing intermediate of donepezil
KR100799821B1
Novel imatinib camsylate and method for preparing thereof
CA2637336A1
Novel benzamidine derivatives, process for the preparation thereof and pharmaceutical composition comprising the same
KR20070081294A
Composition for preventing and curing osteoporosis comprising two terpenoids, fraction or extract from euphorbia kansui
CA2592733A1
Pharmaceutical composition for treating nephropathy and healthy food comprising herb extracts
CN101056658A
Has the oral formulations that improves bioavailability
CN1997367A
Composition for the prevention and treatment of allergic inflammatory disease
BRPI0513034A
improved process for preparing n-hydroxy-4- {5- [4- (5-isopropyl-2-methyl-1,3-thiazol-4-yl) -phenoxy] -pentoxy} -benzamidine
KR20060060970A
Radioactive chitosan complex having an improved stabilized gelation in administering them to the body and their preparation method
KR20060025076A
A method for preparing radioactive film
KR20050025933A
Composition and kit containing the radioisotope-chitosan complex for treatment of prostate cancer
KR20060017929A
Novel benzamidine derivatives substituted by thiazole derivatives, a process for the preparation thereof and pharmaceutical composition comprising the same
KR20050100890A
Composition comprising the extract of acanthopanax sessiliflorus and green tea for treating or alleviating hangover syndrome
KR20050001548A
Pharmaceutical compositions for antidiarrhea
KR20020079654A
Intermediate of carbapenem antibiotics and process for the preparation thereof
KR20030081762A
A quinoline carboxylic acid derivative with fluoropyrrolidine substituents and a process for the preparation thereof
KR20030075396A
Matrix metalloproteinase activity inhibitor and functional food containing flavonoid derivatives or extracts of dalbergia odorifera therewith
WO02074300A1
Composition for treating arteriosclerosis comprising 3-(4'-hydroxyl-3',5'-dimethoxyphenyl)propionic acid or its derivatives
